BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28034364)

  • 1. In silico Analysis of Toxins of Staphylococcus aureus for Validating Putative Drug Targets.
    Mohana R; Venugopal S
    Infect Disord Drug Targets; 2017; 17(2):130-142. PubMed ID: 28034364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NVC-422 inactivates Staphylococcus aureus toxins.
    Jekle A; Yoon J; Zuck M; Najafi R; Wang L; Shiau T; Francavilla C; Rani SA; Eitzinger C; Nagl M; Anderson M; Debabov D
    Antimicrob Agents Chemother; 2013 Feb; 57(2):924-9. PubMed ID: 23208720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of Staphylococcus aureus toxins using immuno-PCR].
    Maerle AV; Riazantsev DIu; Dmitrenko OA; Petrova EIa; Komaleva RL; Sergeev IV; Trofimov DIu; Zavriev SK
    Bioorg Khim; 2014; 40(5):571-7. PubMed ID: 25895352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Monocyte-Derived Osteoclasts Are Targeted by Staphylococcal Pore-Forming Toxins and Superantigens.
    Flammier S; Rasigade JP; Badiou C; Henry T; Vandenesch F; Laurent F; Trouillet-Assant S
    PLoS One; 2016; 11(3):e0150693. PubMed ID: 26934588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of toxin genes by polymerase chain reaction in Staphylococcus aureus strains isolated from bovine mastitis in Turkey.
    Karahan M; Açik MN; Cetinkaya B
    Foodborne Pathog Dis; 2009 Oct; 6(8):1029-35. PubMed ID: 19642915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biofilm formation and virulence factor analysis of Staphylococcus aureus isolates collected from ovine mastitis.
    Azara E; Longheu C; Sanna G; Tola S
    J Appl Microbiol; 2017 Aug; 123(2):372-379. PubMed ID: 28561911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virulence factors and genetic characteristics of methicillin-resistant and -susceptible Staphylococcus aureus isolates in Myanmar.
    Aung MS; Urushibara N; Kawaguchiya M; Aung TS; Mya S; San T; Nwe KM; Kobayashi N
    Microb Drug Resist; 2011 Dec; 17(4):525-35. PubMed ID: 21834665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virulence factors and clonal diversity of Staphylococcus aureus in colonization and wound infection with emphasis on diabetic foot infection.
    Shettigar K; Murali TS
    Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2235-2246. PubMed ID: 32683595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of staphylococcal toxic shock syndrome with linezolid: a case report and in vitro evaluation of the production of toxic shock syndrome toxin type 1 in the presence of antibiotics.
    Stevens DL; Wallace RJ; Hamilton SM; Bryant AE
    Clin Infect Dis; 2006 Mar; 42(5):729-30. PubMed ID: 16447124
    [No Abstract]   [Full Text] [Related]  

  • 10. Staphylococcal purpura fulminans: a toxin-mediated disease?
    Chambers HF
    Clin Infect Dis; 2005 Apr; 40(7):948-50. PubMed ID: 15824984
    [No Abstract]   [Full Text] [Related]  

  • 11. Methicillin-resistant Staphylococcus aureus toxic shock syndrome.
    Walden A; Harriet H; Alyaqoobi M
    J Infect; 2008 Feb; 56(2):161-2. PubMed ID: 18082891
    [No Abstract]   [Full Text] [Related]  

  • 12. Staphylococcus aureus nasal carriage, virulence traits, antibiotic resistance mechanisms, and genetic lineages in healthy humans in Spain, with detection of CC398 and CC97 strains.
    Lozano C; Gómez-Sanz E; Benito D; Aspiroz C; Zarazaga M; Torres C
    Int J Med Microbiol; 2011 Aug; 301(6):500-5. PubMed ID: 21570348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staphylococcal toxins in human disease.
    Arbuthnott JP; Coleman DC; de Azavedo JS
    Soc Appl Bacteriol Symp Ser; 1990; 19():101S-107S. PubMed ID: 2119059
    [No Abstract]   [Full Text] [Related]  

  • 14. Purpura fulminans due to Staphylococcus aureus.
    Kravitz GR; Dries DJ; Peterson ML; Schlievert PM
    Clin Infect Dis; 2005 Apr; 40(7):941-7. PubMed ID: 15824983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of genes for enterotoxins, toxic shock syndrome toxin 1 and exfoliative toxin among clinical isolates of Staphylococcus pseudintermedius from canine origin.
    Yoon JW; Lee GJ; Lee SY; Park C; Yoo JH; Park HM
    Vet Dermatol; 2010 Oct; 21(5):484-9. PubMed ID: 20500497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enterotoxin production by Staphylococcus aureus isolates from cases of septicaemia and from healthy carriers.
    Humphreys H; Keane CT; Hone R; Pomeroy H; Russell RJ; Arbuthnott JP; Coleman DC
    J Med Microbiol; 1989 Mar; 28(3):163-72. PubMed ID: 2926789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SaeRS Two-Component System Is a Direct and Dominant Transcriptional Activator of Toxic Shock Syndrome Toxin 1 in Staphylococcus aureus.
    Baroja ML; Herfst CA; Kasper KJ; Xu SX; Gillett DA; Li J; Reid G; McCormick JK
    J Bacteriol; 2016 Oct; 198(19):2732-42. PubMed ID: 27457715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α-Hemolysin activity of methicillin-susceptible Staphylococcus aureus predicts ventilator-associated pneumonia.
    Stulik L; Malafa S; Hudcova J; Rouha H; Henics BZ; Craven DE; Sonnevend AM; Nagy E
    Am J Respir Crit Care Med; 2014 Nov; 190(10):1139-48. PubMed ID: 25303310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Typing and Virulence Gene Profiles of Enterotoxin Gene Cluster (egc)-Positive Staphylococcus aureus Isolates Obtained from Various Food and Clinical Specimens.
    Song M; Shi C; Xu X; Shi X
    Foodborne Pathog Dis; 2016 Nov; 13(11):592-601. PubMed ID: 27792397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotyping of Staphylococcus aureus in bovine mastitis and correlation to phenotypic characteristics.
    Artursson K; Söderlund R; Liu L; Monecke S; Schelin J
    Vet Microbiol; 2016 Sep; 193():156-61. PubMed ID: 27599942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.